| Abstract | Each year, almost 3500 children are diagnosed with leukemia, representing approximately 30% of pediatric cancer cases. Acute lymphoblastic leukemia is the most common form of pediatric leukemia, accounting for approximately 80% of cases. A significant number of children fail to respond to existing chemotherapies or are unable to maintain remission. Their prognosis is poor, with little hope for long-term survival. |
| Authors | Lisa R McDonald, Colleen H McCarthy
(Affiliation: University of Texas M.D. Anderson Cancer Center, Houston, USA. lrmcdona at mdanderson.org)
|
| Journal | Clinical journal of oncology nursing
(Clin J Oncol Nurs)
Vol. 10
Issue 6
Pg. 809-15
(Dec 2006)
ISSN: 1092-1095 United States |
| PMID | 17193947
(Publication Type: Journal Article, Review)
|
| Chemical References |
- Adenine Nucleotides
- Arabinonucleosides
- clofarabine
|
| Topics |
- Adenine Nucleotides
(adverse effects, therapeutic use)
- Arabinonucleosides
(adverse effects, therapeutic use)
- Child
- Clinical Trials, Phase II as Topic
- Drug Administration Schedule
- Drug Monitoring
- Humans
- Nurse's Role
- Oncologic Nursing
(organization & administration)
- Practice Guidelines as Topic
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, epidemiology, nursing)
- Prognosis
- Recurrence
- Remission Induction
- Survival Rate
- Treatment Outcome
|
